Diaceutics Convergence Meeting

Diaceutics has organised a unique personalized medicine event in Dublin 21st 22nd of October, involving high profile experts from different stakeholder settings in a discussion forum for the advance of Personalised medicine.

Diaceutics Convergence Meeting aims to provide a 360 on the big infrastructure issues holding back commercialization of personalized medicine.

These include integration of disruptive technologies into treatment pathways, regulatory and access gaps, physician education and competitive collaboration.

The skill and experience base of attendees, alongside an agenda focused on structured discussion versus “presentations”, will ensure seasoned Personalized medicine experts tackle the themes.

A greater understanding and of personalized medicine commercialization will be enabled by in depth analysis and immersion with executives in the front line of PM delivery.

Among those attending are individuals from Big Pharma like Novartis and BMS, Diagnostic companies like Qiagen and Ventana, Clinical experts from Mount Sinai and Institut Curie, Pathologists and clinical Laboratory experts from MDAnderson Cancer Center and Vall de Hebron, alongside Foundations like Bill and Melinda Gates and communications experts like Adelphi.

The agenda for the meeting is here: www.diaceutics.com/CM/program.html

Leave a Reply